Rs 3.5 lakh obesity claim ruling puts UAE bariatric documentation under scrutiny

UAE bariatric clinics, insurers and patients should treat a Kerala consumer ruling on a Rs 3.2 lakh sleeve gastrectomy claim as a documentation warning, after the court ordered the insurer to pay Rs 3,50,266.

The Economic Times reported on 12 September 2026 that the Ernakulam District Consumer Disputes Redressal Commission rejected National Insurance Company's position that laparoscopic sleeve gastrectomy was an excluded obesity treatment. The patient records cited high blood pressure, weight gain, breathlessness and knee joint problems.

For Dubai operators, the case matters because the Dubai Health Authority (DHA) regulates providers in a market where many entry-level policy schedules exclude surgical and non-surgical obesity treatment. The P&L issue is direct: a rejected prior approval can turn an AED 25,000 to AED 45,000 cash procedure into a complaint, write-off or patient-acquisition problem.

What the Indian ruling changes for UAE operators

The Indian ruling has no legal force in the UAE. Its operating lesson is still relevant. The commission found that an insurer could not rely on an exclusion clause alone when the medical record showed multiple clinical indications and the insurer produced no expert opinion.

In Dubai, the provider should prepare a claim file that separates cosmetic weight loss from medically indicated metabolic or bariatric treatment. The file should include BMI, comorbidities, failed non-surgical management, procedure codes, surgeon notes, anaesthesia clearance and dietitian follow-up. The same discipline applies in Abu Dhabi under the Department of Health Abu Dhabi (DOH), and in the northern emirates under the Ministry of Health and Prevention (MOHAP).

• Adult BMI threshold: Cleveland Clinic Abu Dhabi lists bariatric surgery as an option at BMI 40 or higher, or BMI 35 to 39.9 with conditions such as type 2 diabetes, high blood pressure or severe sleep apnoea.
• Coverage gate: Daman's obesity adjudication rule says surgical management of morbid obesity is limited to plans with a specific benefit and the schedule of benefits for each plan.
• Comorbidity list: Daman names type 2 diabetes, dyslipidaemia, hypertension, obstructive sleep apnoea, disabling arthropathy and non-alcoholic fatty liver disease among conditions that can improve with weight loss.
• Coding point: Daman requires obesity or morbid obesity ICD-10-CM coding with a secondary diagnosis code for BMI.

Abu Dhabi is moving faster on weight management coverage

Abu Dhabi is the more active reimbursement market for obesity management. DOH and the Abu Dhabi Public Health Centre launched a personalised weight management programme on 19 June 2025 for eligible Thiqa members aged 18 and above who are clinically identified as overweight or obese.

The Thiqa reimbursement policy for obesity management medications applies to adults aged 18 and above. It covers obesity management medication when criteria are met, including BMI 30.0 to 34.9 with at least one listed complication such as hypertension, severe asthma, disabling arthropathy, dyslipidaemia, fatty liver disease or severe obstructive sleep apnoea.

The policy sets a reimbursement test. After the first 4 months, the prescriber must assess effectiveness. If the patient loses more than 5% of initial body weight but fails lifestyle-change compliance, the first 4 months of medication are not reimbursed, although another 3 months may be covered on direct billing. That gives CFOs and revenue-cycle teams a measurable risk point.

What providers should do before submitting a claim

UAE clinics should assume obesity claims will be judged on benefit design, clinical indication and documentation. Daman's adjudication rule states that obesity treatment is not covered where a plan has a general exclusion, and that coverage is restricted by the schedule of benefits even when comorbidities or failed treatment attempts exist. Sukoon and other DHA-participating insurers may use plan-specific exclusions, so providers should check the exact member schedule before quoting coverage.

COOs should set a pre-authorisation checklist for every bariatric or metabolic case. CFOs should track approvals, denials, patient deposits and appeal outcomes by payer. Medical directors should require surgeon, dietitian and physician notes to state why the procedure addresses a medical condition, with dates and test values.

Patients should ask for three documents before surgery: the insurer's written pre-authorisation, the facility's itemised package price and the medical-necessity letter. Where the insurer rejects a claim, the first appeal should attach the comorbidity record and ask whether the denial is based on the policy schedule, a coding issue or a medical opinion.

For licensed nutrition and dietetics support in Dubai, Abu Dhabi and the northern emirates, readers can use the UAE Open Healthcare Directory to find regulated providers before starting a covered or self-pay weight management pathway.